An observational study in Guillain-Barre Syndrome, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Year to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Assiut University · Observational
This prospective observational study aims to evaluate peripheral nerve ultrasound findings, particularly nerve cross-sectional area, in children with Guillain-Barré syndrome.
Guillain-Barré syndrome is an acute immune-mediated neuropathy. High-resolution peripheral nerve ultrasound can measure nerve cross-sectional area and detect structural abnormalities.
This observational study will perform peripheral nerve ultrasound and nerve conduction studies in children aged 1 to 17 years with Guillain-Barré syndrome at baseline and at 3 months.
85 studies on the registry are indexed under Guillain-Barre Syndrome; 29 are open to participants now.
This study's planned enrollment of 42 is below the median of 100 across 41 observational studies indexed under Guillain-Barre Syndrome.
Browse Guillain-Barre Syndrome studies →Assiut University is the lead sponsor of 4,916 studies on the registry; 2,113 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Children aged 1 to 17 years diagnosed with Guillain-Barré syndrome admitted to or evaluated at Assiut University Children's Hospital.
Exclusion Criteria:
Children aged 1 to 17 years with Guillain-Barré syndrome undergoing peripheral nerve ultrasound and nerve conduction studies.
Mean nerve cross-sectional area
Mean cross-sectional area of selected peripheral nerves measured by high-resolution ultrasound in mm².
Time frame: Baseline
Change in nerve cross-sectional area
Mean change in peripheral nerve cross-sectional area in mm² from baseline to 3 months.
Time frame: At 3 months
Mean distal motor latency
Mean distal motor latency measured by nerve conduction study in milliseconds.
Time frame: Baseline
Mean compound muscle action potential amplitude
Mean compound muscle action potential amplitude measured by nerve conduction study in millivolts.
Time frame: Baseline
GBS Disability Scale Score
Mean Guillain-Barré Syndrome disability scale score (range 0 to 6, higher scores indicate worse disability).
Time frame: Baseline
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University